← Back to Screener
Artivion, Inc. (AORT)
Price$38.80
Favorite Metrics
Price vs S&P 500 (26W)-14.92%
Price vs S&P 500 (4W)-2.67%
Market Capitalization$1.89B
P/E Ratio (Annual)193.48x
All Metrics
P/CF (Annual)47.39x
Book Value / Share (Quarterly)$9.37
P/TBV (Annual)7.41x
Revenue Growth (3Y)12.04%
Cash Flow / Share (Quarterly)$0.02
Price vs S&P 500 (YTD)-21.44%
Gross Margin (TTM)64.40%
Net Profit Margin (TTM)2.21%
EPS (TTM)$0.20
10-Day Avg Trading Volume0.46M
EPS Excl Extra (TTM)$0.20
Revenue Growth (5Y)11.75%
EPS (Annual)$0.21
ROI (Annual)1.46%
Gross Margin (Annual)64.40%
Net Profit Margin (5Y Avg)-4.20%
Cash / Share (Quarterly)$1.36
P/E Basic Excl Extra (TTM)193.48x
Revenue Growth QoQ (YoY)19.20%
P/E Normalized (Annual)193.48x
ROA (Last FY)1.10%
Revenue Growth TTM (YoY)13.59%
EBITD / Share (TTM)$1.01
ROE (5Y Avg)-5.05%
Operating Margin (TTM)5.46%
Cash Flow / Share (Annual)$0.02
P/B Ratio4.22x
P/B Ratio (Quarterly)4.82x
Net Income / Employee (Annual)$0
EV / Revenue (TTM)4.63x
Net Interest Coverage (TTM)1.79x
ROA (TTM)1.16%
EV / EBITDA (TTM)43.32x
EPS Incl Extra (Annual)$0.21
Current Ratio (Annual)3.53x
Quick Ratio (Quarterly)2.20x
3-Month Avg Trading Volume0.41M
52-Week Price Return63.43%
EV / Free Cash Flow (Annual)2435.66x
P/E Incl Extra (TTM)193.48x
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$6.10
P/S Ratio (Annual)4.28x
Asset Turnover (Annual)0.50x
52-Week High$48.25
Operating Margin (5Y Avg)2.27%
EPS Excl Extra (Annual)$0.21
CapEx CAGR (5Y)39.74%
26-Week Price Return-6.17%
Quick Ratio (Annual)2.20x
13-Week Price Return-11.25%
Total Debt / Equity (Annual)0.49x
Current Ratio (Quarterly)3.53x
Enterprise Value$2,043.519
Revenue / Share Growth (5Y)6.95%
Asset Turnover (TTM)0.52x
Book Value / Share Growth (5Y)-1.62%
Revenue / Employee (Annual)$0
Inventory Turnover (Annual)1.82x
Pretax Margin (Annual)3.35%
Cash / Share (Annual)$1.36
3-Month Return Std Dev40.80%
Gross Margin (5Y Avg)64.76%
Net Income / Employee (TTM)$0
EBITDA CAGR (5Y)29.67%
EBITDA Interim CAGR (5Y)11.44%
ROE (Last FY)2.18%
Net Interest Coverage (Annual)1.79x
EPS Basic Excl Extra (Annual)$0.21
P/FCF (TTM)49.62x
Receivables Turnover (TTM)5.22x
EV / Free Cash Flow (TTM)2435.66x
Total Debt / Equity (Quarterly)0.49x
EPS Incl Extra (TTM)$0.20
Receivables Turnover (Annual)5.22x
ROI (TTM)1.52%
P/S Ratio (TTM)4.28x
Pretax Margin (5Y Avg)-2.88%
Revenue / Share (Annual)$9.36
Tangible BV / Share (Annual)$6.10
Forward P/E108.21x
Free OCF CAGR (5Y)-30.14%
Price vs S&P 500 (52W)28.34%
P/E Ratio (TTM)193.48x
Year-to-Date Return-17.30%
5-Day Price Return-2.20%
EPS Normalized (Annual)$0.21
ROA (5Y Avg)-1.77%
Net Profit Margin (Annual)2.21%
Month-to-Date Return3.00%
Cash Flow / Share (TTM)$-0.05
EBITD / Share (Annual)$1.02
Operating Margin (Annual)5.46%
LT Debt / Equity (Annual)0.48x
P/CF (TTM)47.39x
ROI (5Y Avg)-2.32%
P/E Excl Extra (TTM)193.48x
LT Debt / Equity (Quarterly)0.48x
EPS Basic Excl Extra (TTM)$0.20
P/TBV (Quarterly)7.41x
P/B Ratio (Annual)4.82x
Inventory Turnover (TTM)1.82x
Pretax Margin (TTM)3.35%
Book Value / Share (Annual)$9.37
Price vs S&P 500 (13W)-14.11%
Beta1.50x
P/FCF (Annual)2252.55x
Revenue / Share (TTM)$8.71
ROE (TTM)2.44%
52-Week Low$22.22
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
4.15
4.15
4.15
4.15
Industry Peers — Surgical & Medical Instruments(108)
| Symbol | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|
AORTArtivion, Inc. | 4.28x | 11.75% | 64.40% | 5.46% | $38.80 |
SYKStryker Corporation | 5.17x | 11.84% | 64.57% | 19.43% | $338.34 |
BSXBoston Scientific Corp. | 4.58x | 15.16% | 69.01% | 18.00% | $60.99 |
MMM3M Company | 3.21x | -4.97% | 39.92% | 18.55% | $151.40 |
MDLNMedline Inc. Class A common stock | 2.20x | — | 26.44% | 7.78% | $48.26 |
BDXBecton, Dickinson and Co. | 2.06x | 6.32% | 46.42% | 12.15% | $158.64 |
RMDResMed Inc. | 6.07x | 11.72% | 60.85% | 33.70% | $226.14 |
DXCMDexCom, Inc. | 5.33x | 19.33% | 62.09% | 19.56% | $64.62 |
WSTWest Pharmaceutical Services, Inc. | 6.29x | 7.44% | 35.91% | 19.03% | $278.00 |
PODDInsulet Corporation | 5.19x | 24.53% | 71.63% | 12.92% | $200.87 |
PENPenumbra, Inc. | 9.24x | 20.16% | 67.14% | 13.48% | $329.71 |
About
Artivion provides cardiac and vascular surgeons with aortic-centric surgical solutions, including heart valves, stent grafts, patches, and surgical sealants. The company operates through two segments: Medical Devices (implantable products and surgical tools) and Preservation Services (tissue preservation). With global operations across North America, EMEA, LATAM, and APAC, North America represents its largest revenue source.